Curriculum Vitae
Curriculum Vitae
Jorden Brent Weiss, D.O.
Education:
Topeka Institute of Psychoanalysis: 2005
Graduate
Adult Training Program in Psychoanalysis
C.F. Menninger Memorial Hospital, Topeka, KS
Topeka Institute of Psychoanalysis: 1996 to Present
Advanced Candidate
Child Training Program in Psychoanalysis
C.F. Menninger Memorial Hospital, Topeka, KS
Child Psychiatry Fellowship, Karl Menninger School of Psychiatry: July 1998
C.F. Menninger Memorial Hospital, Topeka, KS
Residency and Training Program in Adult Psychiatry, Karl Menninger School of Psychiatry: June 1996
C.F. Menninger Memorial Hospital, Topeka, KS
PGY-3, 4
UCLA/San Fernando Valley-VA Adult Psychiatry Training Program, UCLA Neuropsychiatric Institute: June 1994
Los Angeles, California
PGY-2
Internship: June 1993
Timberlawn Psychiatric Hospital, Dallas, Texas
Baylor University Medical Center, Dallas, Texas
Doctor of Osteopathy: June 1992
University of Osteopathic Medicine and Health Sciences
College of Osteopathic Medicine and Surgery, Des Moines, Iowa
Bachelor of Science: Biology, June 1988
UCLA College of Letters and Science, Los Angeles, California
Board Certification:
July 1993: Diplomate of the National Board of Osteopathic Medical Examiners
Licensures:
July 1998-Present: State Medical Board of Ohio,
License Number 34-00-6906-W
January 1, 1997: State of Missouri Registration for the Healing Arts-Physician and Surgeon, Certificate #111828
June 5, 1994: Kansas State Board of Healing Arts-Medicine and Surgery, Certificate #05-25161
March 3, 1993: Osteopathic Medical Board of California-Physician and Surgery, Certificate #20A6593
June 20, 1994: United States Department of Justice Drug Enforcement Agency License to Dispense Controlled Substances Certificate #BW4240230
Employment:
June 2009- Present: Alkire Creek Psychiatry, A Center For Growth and Mindfulness; Medication Management, Psychotherapy and Psychoanalysis; Adult, Child and Adolescent Psychiatry and Psychotherapy; Director
July 2006- Present: The Center for Balanced Living, The diagnosis and treatment of eating disorders in adults, children and adolescents, Psychopharmacology and Psychotherapy
November 2001- 2005: Amigo Family Counseling, Adult, Child and Adolescent Psychopharmacolgy and Consultation
August 2000-Present: Pinnacle Behavioral Health, LLC, Adult, Child and Adolescent Psychiatry, Psychopharmacology, Adult and Child Psychoanalysis, Private Practice, Partner/Owner
July 1998-2000: OSU-Harding Hospital, Adult, Child and Adolescent Psychiatry, Adult and Child Psychoanalysis, Out Patient Division
July 1996-1998: C.F. Menninger Memorial Hospital, Childrens’ Division, Neuropsychiatric Officer on Duty, After-hour emergency admissions and consultations and first call for entire Childrens’ Hospital.
July 1996-1998: Kansas Neurological Institute, Topeka, KS, Medical House Officer on Duty, After-hour emergency admissions and consultations and first call for entire 200-bed hospital.
July 1996-June 1998: C.F. Menninger Memorial Hospital, Childrens’ Division, emergency admissions and consultations in addition to regular clinical duties as a “sunlighter” clinician.
July 1996-July 1997: Family Service and Guidance Center, Topeka, KS, Psychiatric consultations and evaluations for adult and children, pharmacotherapy clinic.
July 1994-June 1997: Topeka State Hospital, Topeka, Kansas, Neuropsychiatric House Officer on Duty, admissions and consultations and first call for entire 240-bed Adult and Childrens’ Hospital.
July 1994-June 1997: Kansas State Corrections and Educational Treatment Unit, Topeka, Kansas, Medical and neuropsychiatric consultations and first call for 20 bed adolescent treatment and rehabilitation corrections unit.
January 1995-July 1995: C.F. Menninger Memorial Hospital, Adult Division, emergency admissions and consultations in addition to regular clinical duties as a “sunlighter” clinician.
July 1993-June 1994: UCLA/Olive View Medical Center, Los Angeles, California, Neuropsychiatric House Officer on Duty, Psychiatry Emergency Room, admissions and consultations and first call for busy medical and psychiatric emergency rooms.
ACADEMIC APPOINTMENTS:
1999-Present: Clinical Assistant Professor of Psychiatry, Ohio State University.
Research:
1997-1998: Vanguard Medica Ltd., Protocol VML 251/96/08, A 12-Month Study of VML251 in the Acute Treatment of Migraine. Subinvestigator under the direction of Walter Menninger, M.D. and Patricia Solbach, Ph.D., The Menninger Clinic, Clinical Research Department, Topeka, Kansas.
1997-1998: Wyeth-Ayerst, Protocol 0927B1-300-US, A Double-Blind, Placebo-Controlled Study of Efficacy and Safety of Sustained Release Dexfenfluramine in Obese Outpatients. Subinvestigator under the direction of Arundhati Desai, M.D. and Patricia Solbach, Ph.D., The Menninger Clinic, Clinical Research Department, Topeka, Kansas.
1997-1998: SmithKline Beecham, Protocol 29060-497, A Double-Blind, Placebo Controlled, Flexible Dosing Trial to Evaluate the Efficacy of Modified Release Paroxetine in the Treatment of Panic Disorder. Subinvestigator under the direction of Edward Eaton, M.D. and Patricia Solbach, Ph.D., The Menninger Clinic, Clinical Research Department, Topeka, Kansas.
1997-1998: Bristol-Myers Squibb, Protocol CN104-146-004, A Multicenter Double-Blind Trial of Nefazodone in the Prophylactic Treatment of Patients with Migraine. Subinvestigator under the direction of Walter Menninger, M.D. and Patricia Solbach, Ph.D., The Menninger Clinic, Clinical Research Department, Topeka, Kansas.
1997-1998: Bristol-Myers Squibb, Protocol CN101-093, A Double-Blind, Randomized, Placebo Controlled, Flexible Dose Trial of 30CM2 Transdermal Buspirone Patches in the Treatment of Anxious Outpatients. Subinvestigator under the direction of Peter Schram, M.D. and Patricia Solbach, Ph.D., The Menninger Clinic, Clinical Research Department, Topeka, Kansas.
1997-1998: Hoechst Marion Roussel, Inc. Protocol 100907PR0018, A Multicenter, Open-Label, Long-Term Follow up, Safety Study of MDL100, 907 in Schizophrenic and Schizoaffective Patients Who Participate in the Study 100907PR0015. Subinvestigator under the direction of Joyce Davidson, M.D. and Patricia Solbach, Ph.D., The Menninger Clinic, Clinical Research Department, Topeka, Kansas.
1997-1998: SmithKline Beecham, Protocol 29060/453, A 38-week, Two Phase, Multicenter Study to Investigate the Safety and Effectiveness of Paroxetine (10-60 mg/day) in the Treatment of Children and Adolescent Outpatients with Obsessive-Compulsive Disorder. Subinvestigator under the direction of Efrain Bleiberg, M.D., The Menninger Clinic, Clinical Research Department, Topeka, Kansas.
1996-1997: Hoechst Marion Roussel, Inc. Protocol 100907PR0015, A Multicenter, Randomized, Double-Blind, Placebo and Active Controlled Study of MDL100, 907 in Schizophrenic and Schizoaffective Patients. Subinvestigator under the direction of Joyce Davidson, M.D. and Patricia Solbach, Ph.D., The Menninger Clinic, Clinical Research Department, Topeka, Kansas.
1996-1997: Zeneca, Protocol for a Multicenter, Long-Term Study to Maximize Migraine Relief with 311C90 (MAXIMM). Subinvestigator under the direction of Patricia Solbach, Ph.D., The Menninger Clinic, Clinical Research Department, Topeka, Kansas.
1996-1997: Pfizer, Inc., A Multicenter, Double-Blind, Randomized, Placebo-Controlled Parallel Group Study of the Efficacy and Safety of Oral Eletriptan in Subjects with Acute Migraine. Subinvestigator under the direction of Walter Menninger, M.D. and Patricia Solbach, Ph.D., The Menninger Clinic, Clinical Research Department, Topeka, Kansas.
1996-1997: Eli-Lilly & Co., Protocol B1Y-MC-HZAA(a) “Fluoxetine Plus Pindolol Versus Fluoxetine Plus Placebo in the Treatment of Major Depression.” Subinvestigator under the direction of John Whipple, M.D. and Patricia Solbach, Ph.D., The Menninger Clinic, Clinical Research Department, Topeka, Kansas.
1996-1997: Eli-Lilly & Co., Protocol B1Y-MC-HCIE “Fluoxetine verses Placebo in Bulimia Relapse Prevention.” Subinvestigator under the direction of Katherine Zerbe, M.D., The Menninger Clinic, Clinical Research Department, Topeka, Kansas.
1995-1996: Bristol-Myers Squibb Protocol CN 115-038, An Open Label Long-Term Trial Evaluating the Safety of BMS-180048 150 mg. in the Treatment of Patients with Migraine Headache with and without Aura. Subinvestigator under the direction of Walter Menninger, M.D. and Patricia Solbach, Ph.D., The Menninger Clinic, Clinical Research Department, Topeka, Kansas.
1995-1996: Merck, Protocol 025-00, A Randomized, Triple-Blind, Placebo-Controlled, Outpatient Study to Examine the Safety and Efficacy of MK-462 10 mg. p.o. in the Treatment of Multiple Attacks of Migraine Headache Extension Phase. Subinvestigator under the direction of Patricia Solbach, Ph.D., The Menninger Clinic, Clinical Research Department, Topeka, KS.
1995: Janssen Pharmaceutical Inc., Protocol RIS-USA-68-01, A Bioequivalence Study Comparing an 8 mg. Risperidone Tablet with Two 4 mg. Risperidone Tablets in Chronic Schizophrenia Patients. Subinvestigator under the direction of Joyce Davidson, M.D. and Patricia Solbach, Ph.D., The Menninger Clinic, Clinical Research Department, Topeka, Kansas.
1976-1978: Antigen-Induced Tumor Cell Markers in Mice. Subinvestigator under the direction of Ralph Reisfeld, Ph.D., Scripps Clinic and Research Foundation, La Jolla, California.
Professional Affiliations:
1998-present: American Academy of Child and Adolescent Psychiatry
1996-present: American Psychoanalytic Association
1991-present: American Psychiatric Association
1988-present: American Medical Association
1988-present: American Osteopathic Association
Hospital Affiliations AND PRIVILEGES:
1999-present: Ohio State University Medical Center, Columbus, Ohio
1998-present: Harding Hospital, Columbus, Ohio
1994-1998: C.F. Menninger Memorial Hospital, Topeka, Kansas
1996-1998: Kansas Neurological Institute, Topeka, Kansas
1994-1997: Topeka State Hospital, Topeka, Kansas
1993-1994: UCLA Neuropsychiatric Institute, Los Angeles, California
1993-1994: UCLA/Olive View County Medical Center, Los Angeles, California
1993-1994: UCLA/San Fernando Valley-VA Medical Center, Los Angeles, California
Consultations:
1997-1998: Topeka 501 School District, Psychiatric evaluations for Children and adolescents, family consultations, and in-service psychoeducational training sessions for staff.
1996-1997: Pediatric Associates PA, Topeka, Kansas, Psychiatric evaluations and pharmacotherapy assessments for children and adolescents, family assessments and consultations with pediatricians regarding neuropsychiatric treatment recommendations for patients.
1996-1997: Topeka Association for Retarded Citizens, Psychiatric consultations of families, psychoeducational training sessions for staff and families, psychiatric support and assistance for staff.
1995-1996: Legal Aid Clinic of Topeka, In-service training for attorneys regarding psychiatric treatment issues of their clients, medical and neuropsychiatric reviews of cases and recommendations.
1995-1996: Vocational Rehabilitation Center of Topeka, Neuropsychiatric evaluations of adults and adolescents, pharmacotherapy and treatment recommendations.
1994-1995: Topeka State Hospital, Forensic evaluations and reports including court testimonial experience with treatment recommendations.
Educational Activities:
2003: ADHD Challenges In Pharmacotherapy, Regional Faculty Leader, Dannmiller Memorial Educational Foundation and Medical Decision Point
2002: Psychodynamic Psychiatry course taught to senior psychiatry residents and Child Psychiatry Fellows, OSU/Harding Hospital
1996: Supervision of senior medical students on busy child and adolescent inpatient unit, C.F. Menninger Memorial Hospital, Childrens’ Division, with coordination of seminars and lecture topics relevant to neuropsychiatry and psychoanalysis.
1995: Supervision of senior medical students in a busy outpatient facility, C.F. Menninger Memorial Hospital, Community Service Office, Child and adolescent psychiatry, with coordination of seminars and lecture topics relevant to child and adult neuropsychiatry.
1995: Taught course with Marceil Bauman-Bork, M.D. on Emergency Psychiatry to Family Practice Residents from Stormont-Vail Hospital Family Practice Residency Program, Topeka, Kansas.
1994: Supervision of senior medical students on a busy inpatient unit, C.F. Menninger Memorial Hospital, Adult Division, CASE Unit, with coordination of seminars and lecture topics relevant to neuropsychiatry.
1993-1994: Supervision of senior medical students on busy adult crisis and stabilization unit, UCLA/Olive View Medical Center, Los Angeles, California, with coordination of seminars and lecture topics relevant to neuropsychiatry and community psychiatry.
1993-1994: Interviewer of applicants to UCLA/San Fernando Valley Training Program in Adult Psychiatry.
1992-1993: Supervision of senior medical students on busy adult inpatient unit, Timberlawn Psychiatric Hospital, Dallas, Texas, with coordination of seminars and lecture topics relevant to neuropsychiatry.
1992-1993: Supervision of senior medical students on busy medical ward, Baylor University Medical Center, Dallas, Texas, with coordination of seminars and lecture topics relevant to internal medicine and neuropsychiatry.
1992-1993: Intensive training course in ECT, Timberlawn Psychiatric Hospital, Dallas, Texas, completion of 150 hours of ECT clinical experience.
LECTURES AND Presentations:
August 15, 2004: CME Presentation, Grand Rounds: Autistic Spectrum Disorders: Comorbidities and Treatment Outcome Expectations, Foxrun Psychiatric Hospital, St. Clairsville, Ohio
August 14, 2004: Presentation: New Treatment Paradigms In the Treatment of Acute Mania and Bipolar Disorder “Across the Ages”, Eastern Ohio Psychiatric Society, St. Clairsville, Ohio
June 8, 2004: Presentation: A New First Line Treatment For Attention Deficit Hyperactivity Disorder In Adult and Children, Amigo Family Counseling, Columbus Ohio
June 1, 2004: CME Lecture: Clinical Insights: Antipsychotic Therapy For Bipolar Mania, Lancaster Family Practice Association, Lancaster, OH
May 20, 2004: CME Presentation, Grand Rounds: Attention Deficit Hyperactivity Disorder- How Does It Present in Adults and How Do We Treat It? Mount Carmel Hospital, Columbus, Ohio
May 3, 2004: Presentation: Monoaminergic Pathways and Their Impact On Cognitive Function and Depression- The Psychopharmacology of Energy and Fatigue, Psychiatry, Neurology, and Nurse Practitioner audience, Wichita, Kansas
April 13, 2004: CME Presentation: Children and Bipolar Disorder, Tri-County Mental Health & Counseling Services, Athens, OH
March 2, 2004: Presentation: Histamine and It’s Impact on the Frontal Cortex- Novel Treatment Approaches In the Psychopharmacology of Depression and Fatigue, Consolidated Care, Inc., West Liberty, Ohio
February 10, 2004: Presentation: Bipolar Disorder In Children and Adolescents- Variations On An Adult Theme, Dayton Psychiatric Society, Dayton, Ohio
January 21, 2004: CME Presentation: ADHD Challenges In Pharmacotherapy, Dannmiller Memorial Educational Foundation Regional Lecture, Columbus, Ohio
November 11, 2003: CME Presentation: Aspergers Syndrome and Pervasive Developmental Disorders- Identification and Biopsychosocial Treatment Paradigms, Dover County Mental Health Center, New Philadelphia, Ohio
October 16, 2003: Presentation: Antipsychotic Use in Special Populations, Central Ohio Counseling Services, Worthington, OH
September 21, 2003: Presentation: Clinical Perspectives On New Treatment Options for Attention-Deficit Hyperactivity Disorder, Newark Pediatric Associates, Newark, OH
September 16, 2003: Presentation: Antipsychotic Use in Special Populations, Central Ohio Counseling Services, Worthington, OH
August 20, 2003: Presentation: ADHD and Comorbidities, Ross Pediatrics and Associates, Oregonia, OH
August 19, 2003: Presentation: Current Issues in the Management of Sleep Disorders in Psychiatry, Mount Carmel Psychiatric Services, Columbus, OH
August 1, 2003: CME Presentation: Bipolar Disorder In Child and Adolescent Populations- Comorbidities and New Treatment Paradigms, Kahi Mohala Psychiatric Hospital, Honolulu, Hawaii
July 24, 2003: CME Presentation: Attention Deficit Hyperactivity Disorder and Comorbid Conditions- New Treatment Paradigms and Strategies, Cincinnati Children’s Home, Cincinnati, OH
July 23, 2003: CME Presentation: Clinical Perspectives On New Treatment Options For Attention Deficit Hyperactivity Disorder, University of Cincinnati-Central Clinic, Cincinnati, OH
July 22, 2003: CME Presentation: Understanding Atypicality- Benefits and Treatment Paradigms in Bipolar Disorder and Psychosis, King’s Daughters Medical Center, Ashland, KY
July 21, 2003: CME Presentation: Antipsychotic Use in Special Populations, Highland Hospital, Charleston, W. Virginia
July 18, 2003: Presentation: Recognition, Diagnosis, and Treatment of Adults with Attention Deficit Hyperactivity Disorder- Clinical Perspectives, Psychiatry, Family Practice, Internal Medicine audience, Westchester, OH
July 11, 2003: Presentation: Clinical Perspectives On New Treatment Options For Attention Deficit Hyperactivity Disorder In Children, William Cotton, M.D. and Associates, Columbus, OH
June 26, 2003: Presentation: Current Issues in the Management of Disorders of Sleep and Wakefulness, Eastern Bay Psychiatric Association, Eerie, Pennsylvania
May 10, 2003: CME Presentation: Psychopharmacology of Energy and Fatigue, Psychiatry, Neurology, and Internal Medicine clinician audience, Topeka, KS
April 15, 2003: Presentation: Bipolar Disorder In the Child and Adolescent Population- Variations On A Theme, Family Service and Guidance Center, Topeka, Kansas
February 27, 2003: Presentation: Recognition, Diagnosis and Treatment of Adults With Attention Deficit Hyperactivity Disorder: Clinical Perspectives, Internal Medicine and Family Practice clinician audience, Columbus, OH
January 21, 2003: Presentation: Cognition, Energy and Fatigue- Monoaminergic Pathways and Their Unique Contributions In The Treatment of Depressed States, Canyon Medical Center, Columbus, Ohio
December 2, 2002: Presentation: Recognition, Diagnosis and Treatment of Adults With Attention Deficit Hyperactivity Disorder, Adult Psychiatry and Internal Medicine audience, Hershey, Pennsylvania
November 12, 2002: Presentation: Attention Deficit Hyperactivity Disorder and Comorbid Conditions, Lancaster Mental Health Mental Retardation Center, Lancaster, Ohio
October 21, 2002: Presentation: Common Affective Disorders In the Pediatric Population- How They May Present and Current Modes of Treatment, West Chester Pediatrics, West Chester, Ohio
September 16, 2002: Presentation: Advances in ADHD- Diagnosis and Treatment, Queen City Physicians, Cincinnati, Ohio
August 5. 2002: Presentation: Recognition, Diagnosis and Treatment of the Depressed Child, Pediatric, Family Practice and paraprofessional audience, Cuyahoga Falls, Ohio
May 21, 2002: CME Presentation: Autism – Current Theories & Thoughts, Children’s Hospital of Columbus, PECS Annual Spring Conference, Columbus, OH
September 14, 2000: Radio presentation and interview: Interviewed and Participant on National Public Radio broadcast: Doctors Rounds, An interview, panel discussion, audience question and answer radio show- Attention Deficit Disorder, broadcast nationally.
February 10, 1996: Case presentation to Guest Lecturer and Clinical Staff at Professional Educational Meeting of C.F. Menninger Memorial Hospital: Transference to Medication in a Combined Psychotherapy and Pharmacotherapy Process: A Challenging Case.
1994-1995: Courses of lectures presented to staff of attorneys at Legal Aid Clinic of Topeka on topics relevant to forensic psychiatry, neuropsychiatry and psychopathology.
October 3, 1994: Lecture to Chaplain Interns on Schizophrenia: Etiology and treatment Issues, Topeka State Hospital, Topeka, Kansas.
Publications:
June 1998: A review of: The Chicago Institute Lectures, Edited by Paul Tolpin and Marion Tolpin. Bulletin of the Menninger Clinic, Spring/Summer Issues, 1998.
1995: Menninger Perspective, Volume 26, Number 2, A School Like No Other, interviewed for an article describing the “art” of training future psychiatrists.
Honors:
1996: Miles Seeley Fellowship in Psychiatry, awarded for superior residency performance.
